PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Polysaccharides (AAPS) significantly prolonged lifespan and alleviated oxidative stress in Drosophila melanogaster and D-galactose-induced aging mice by increasing antioxidant enzyme activity and regulating gut microbiota (increasing Lactobacillus) [PMID:36496591, PMID:38137185].
Neutral fuco-galactoglucans (AAP-0.2A) influence macrophage polarization toward the M1 phenotype, affecting the proliferation and apoptosis of CT26 colorectal cancer cells [PMID:40784381].
Ethanol extracts and polysaccharide-polyphenolic complexes (AMPP) demonstrate anti-quorum sensing and antibiofilm activity, reducing swarming motility [PMID:37835214, PMID:39756726].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 40288850 (2025) — Peroxygenase-catalysed oxyfunctionalisation reactions. · Methods in enzymology
- 2.PMID: 33917246 (2021) — Ageritin from Pioppino Mushroom: The Prototype of Ribotoxin-Like Proteins, a Novel Family of Specific Ribonucleases in Edible Mushrooms. · Toxins
- 3.PMID: 37496955 (2023) — Toward Kilogram-Scale Peroxygenase-Catalyzed Oxyfunctionalization of Cyclohexane. · Organic process research & development
- 4.PMID: 28503801 (2017) — Pioppino mushroom in southern Italy: an undervalued source of nutrients and bioactive compounds. · Journal of the science of food and agriculture
- 5.PMID: 33529432 (2021) — Chromoselective Photocatalysis Enables Stereocomplementary Biocatalytic Pathways*.